… The way we talk says a lot about who we are and how we’re feeling. We may raise our voice when we’re angry, or soften our tone when feeling especially magnanimous. We may talk … and pacing of our speech is an important tool in how we communicate with others. But while changes in speech are …

… outlining the in-depth selection process for its Targets to Therapies Initiative — showcasing MJFF’s robust approach to prioritizing new therapy … like alpha synuclein and LRRK2.   The paper, called " A Community-Led Initiative to De-Risk and Advance Parkinson’s …

… awardee Addex Therapeutics has announced a reorganization to increase focus on developing its clinical pipeline for rare and orphan diseases. The company remains committed to the development of dipraglurant … of PD levodopa-induced dyskinesia,” says Addex CEO Bharatt Chowira. In its announcement, the company states that it will …

… newly discovered induced pluripotent stem cell technology to generate unlimited supply of human dopamine neurons with … why dopamine neurons die when parkin is mutated and how we may prevent it. Project Description: We will change … of the original patients and healthy subjects. We will compare these human dopamine neurons to see how the …

… Age quackery. For others, it’s a source of hope and a way to reconcile their spiritual life with modern science. For … to medical treatment. His family was not strict about it, however; he recalls an incident from his Colorado childhood … that there is not a single placebo effect, but many. One common effect involves the assumption that a particular pill …

… Sometimes, a long-awaited diagnosis can lead to a certain sense of relief. For Florida resident Mike … across The Michael J. Fox Foundation (MJFF) and insisted I get involved — she was wise,” he says.  Mike chose not to … to ease the tremors after I'd been in PPMI for a year, I’m committed to the study for many years to come,” Mike says. …